Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 489,711 | 230,440 |
| TOTAL | $502,533 | $231,073 |
| Non-Current Assets | ||
| PPE Net | 155 | 202 |
| Other Non-Current Assets | 7,308 | 2,707 |
| TOTAL | $7,463 | $2,909 |
| Total Assets | $509,996 | $233,982 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 4,508 | 3,186 |
| Accrued Expenses | 12,875 | 11,614 |
| TOTAL | $17,990 | $15,085 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 131 | 367,666 |
| TOTAL | $131 | $367,666 |
| Total Liabilities | $18,121 | $382,751 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 54,523 | N/A |
| Common Shares | 7 | 2 |
| Retained earnings | -221,016 | -153,021 |
| TOTAL | $491,875 | $-148,769 |
| Total Liabilities And Equity | $509,996 | $233,982 |